CDKN3 and posterior cortical atrophy: Clinical analysis further demonstrated that DOCK3 co-expression with CDKN3 defines a PCa subgroup enriched for high Gleason scores (≥8) and advanced T stage (T3/T4), underscoring its prognostic potential.